The global Cancer Gene Therapy market was valued at US$ 522 million in 2023 and is anticipated to reach US$ 1657.7 million by 2030, witnessing a CAGR of 17.8% during the forecast period 2024-2030.

Cancer Gene Therapy Market

Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cancer Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Therapy.

Report Scope

The Cancer Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Gene Therapy Market Report

Report Metric	Details
Report Name	Cancer Gene Therapy Market
Accounted market size in 2023	US$ 522 million
Forecasted market size in 2030	US$ 1657.7 million
CAGR	17.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oncolytic Virotherapy Gene Transfer Gene-Induced Immunotherapy
Segment by Application	Hospitals Diagnostics Centers Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Adaptimmune, Bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen, Argenx, BioCancell, GlaxoSmithKline, Merck, OncoGenex Pharmaceuticals, Transgene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Gene Therapy Market growing?

Ans: The Cancer Gene Therapy Market witnessing a CAGR of 17.8% during the forecast period 2024-2030.

What is the Cancer Gene Therapy Market size in 2030?

Ans: The Cancer Gene Therapy Market size in 2030 will be US$ 1657.7 million.

Who are the main players in the Cancer Gene Therapy Market report?

Ans: The main players in the Cancer Gene Therapy Market are Adaptimmune, Bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen, Argenx, BioCancell, GlaxoSmithKline, Merck, OncoGenex Pharmaceuticals, Transgene

What are the Application segmentation covered in the Cancer Gene Therapy Market report?

Ans: The Applications covered in the Cancer Gene Therapy Market report are Hospitals, Diagnostics Centers, Research Institutes

What are the Type segmentation covered in the Cancer Gene Therapy Market report?

Ans: The Types covered in the Cancer Gene Therapy Market report are Oncolytic Virotherapy, Gene Transfer, Gene-Induced Immunotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oncolytic Virotherapy

1.2.3 Gene Transfer

1.2.4 Gene-Induced Immunotherapy

1.3 Market by Application

1.3.1 Global Cancer Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Gene Therapy Market Perspective (2019-2030)

2.2 Cancer Gene Therapy Growth Trends by Region

2.2.1 Global Cancer Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Cancer Gene Therapy Market Dynamics

2.3.1 Cancer Gene Therapy Industry Trends

2.3.2 Cancer Gene Therapy Market Drivers

2.3.3 Cancer Gene Therapy Market Challenges

2.3.4 Cancer Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Gene Therapy Players by Revenue

3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2019-2024)

3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue

3.4 Global Cancer Gene Therapy Market Concentration Ratio

3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2023

3.5 Cancer Gene Therapy Key Players Head office and Area Served

3.6 Key Players Cancer Gene Therapy Product Solution and Service

3.7 Date of Enter into Cancer Gene Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Gene Therapy Breakdown Data by Type

4.1 Global Cancer Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Cancer Gene Therapy Breakdown Data by Application

5.1 Global Cancer Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Gene Therapy Market Size (2019-2030)

6.2 North America Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Gene Therapy Market Size by Country (2019-2024)

6.4 North America Cancer Gene Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Gene Therapy Market Size (2019-2030)

7.2 Europe Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Gene Therapy Market Size by Country (2019-2024)

7.4 Europe Cancer Gene Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Gene Therapy Market Size (2019-2030)

8.2 Asia-Pacific Cancer Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Gene Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Gene Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Gene Therapy Market Size (2019-2030)

9.2 Latin America Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Gene Therapy Market Size by Country (2019-2024)

9.4 Latin America Cancer Gene Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Gene Therapy Market Size (2019-2030)

10.2 Middle East & Africa Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Gene Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Adaptimmune

11.1.1 Adaptimmune Company Detail

11.1.2 Adaptimmune Business Overview

11.1.3 Adaptimmune Cancer Gene Therapy Introduction

11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2019-2024)

11.1.5 Adaptimmune Recent Development

11.2 Bluebird bio

11.2.1 Bluebird bio Company Detail

11.2.2 Bluebird bio Business Overview

11.2.3 Bluebird bio Cancer Gene Therapy Introduction

11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2019-2024)

11.2.5 Bluebird bio Recent Development

11.3 Celgene

11.3.1 Celgene Company Detail

11.3.2 Celgene Business Overview

11.3.3 Celgene Cancer Gene Therapy Introduction

11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2019-2024)

11.3.5 Celgene Recent Development

11.4 Shanghai Sunway Biotech

11.4.1 Shanghai Sunway Biotech Company Detail

11.4.2 Shanghai Sunway Biotech Business Overview

11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction

11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2019-2024)

11.4.5 Shanghai Sunway Biotech Recent Development

11.5 Shenzhen SiBiono GeneTech

11.5.1 Shenzhen SiBiono GeneTech Company Detail

11.5.2 Shenzhen SiBiono GeneTech Business Overview

11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction

11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2019-2024)

11.5.5 Shenzhen SiBiono GeneTech Recent Development

11.6 SynerGene Therapeutics

11.6.1 SynerGene Therapeutics Company Detail

11.6.2 SynerGene Therapeutics Business Overview

11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction

11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2019-2024)

11.6.5 SynerGene Therapeutics Recent Development

11.7 Altor BioScience

11.7.1 Altor BioScience Company Detail

11.7.2 Altor BioScience Business Overview

11.7.3 Altor BioScience Cancer Gene Therapy Introduction

11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2019-2024)

11.7.5 Altor BioScience Recent Development

11.8 Amgen

11.8.1 Amgen Company Detail

11.8.2 Amgen Business Overview

11.8.3 Amgen Cancer Gene Therapy Introduction

11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2019-2024)

11.8.5 Amgen Recent Development

11.9 Argenx

11.9.1 Argenx Company Detail

11.9.2 Argenx Business Overview

11.9.3 Argenx Cancer Gene Therapy Introduction

11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2019-2024)

11.9.5 Argenx Recent Development

11.10 BioCancell

11.10.1 BioCancell Company Detail

11.10.2 BioCancell Business Overview

11.10.3 BioCancell Cancer Gene Therapy Introduction

11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2019-2024)

11.10.5 BioCancell Recent Development

11.11 GlaxoSmithKline

11.11.1 GlaxoSmithKline Company Detail

11.11.2 GlaxoSmithKline Business Overview

11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction

11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2019-2024)

11.11.5 GlaxoSmithKline Recent Development

11.12 Merck

11.12.1 Merck Company Detail

11.12.2 Merck Business Overview

11.12.3 Merck Cancer Gene Therapy Introduction

11.12.4 Merck Revenue in Cancer Gene Therapy Business (2019-2024)

11.12.5 Merck Recent Development

11.13 OncoGenex Pharmaceuticals

11.13.1 OncoGenex Pharmaceuticals Company Detail

11.13.2 OncoGenex Pharmaceuticals Business Overview

11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction

11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2019-2024)

11.13.5 OncoGenex Pharmaceuticals Recent Development

11.14 Transgene

11.14.1 Transgene Company Detail

11.14.2 Transgene Business Overview

11.14.3 Transgene Cancer Gene Therapy Introduction

11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2019-2024)

11.14.5 Transgene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Adaptimmune

Bluebird bio

Celgene

Shanghai Sunway Biotech

Shenzhen SiBiono GeneTech

SynerGene Therapeutics

OncoGenex Pharmaceuticals

Transgene

List of Tables

Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oncolytic Virotherapy

Table 3. Key Players of Gene Transfer

Table 4. Key Players of Gene-Induced Immunotherapy

Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cancer Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cancer Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cancer Gene Therapy Market Share by Region (2019-2024)

Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cancer Gene Therapy Market Share by Region (2025-2030)

Table 11. Cancer Gene Therapy Market Trends

Table 12. Cancer Gene Therapy Market Drivers

Table 13. Cancer Gene Therapy Market Challenges

Table 14. Cancer Gene Therapy Market Restraints

Table 15. Global Cancer Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cancer Gene Therapy Market Share by Players (2019-2024)

Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2023)

Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cancer Gene Therapy Product Solution and Service

Table 22. Date of Enter into Cancer Gene Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cancer Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Cancer Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Cancer Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cancer Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cancer Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cancer Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cancer Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cancer Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cancer Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cancer Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cancer Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cancer Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cancer Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cancer Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cancer Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cancer Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cancer Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Adaptimmune Company Detail

Table 48. Adaptimmune Business Overview

Table 49. Adaptimmune Cancer Gene Therapy Product

Table 50. Adaptimmune Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 51. Adaptimmune Recent Development

Table 52. Bluebird bio Company Detail

Table 53. Bluebird bio Business Overview

Table 54. Bluebird bio Cancer Gene Therapy Product

Table 55. Bluebird bio Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 56. Bluebird bio Recent Development

Table 57. Celgene Company Detail

Table 58. Celgene Business Overview

Table 59. Celgene Cancer Gene Therapy Product

Table 60. Celgene Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 61. Celgene Recent Development

Table 62. Shanghai Sunway Biotech Company Detail

Table 63. Shanghai Sunway Biotech Business Overview

Table 64. Shanghai Sunway Biotech Cancer Gene Therapy Product

Table 65. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 66. Shanghai Sunway Biotech Recent Development

Table 67. Shenzhen SiBiono GeneTech Company Detail

Table 68. Shenzhen SiBiono GeneTech Business Overview

Table 69. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product

Table 70. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 71. Shenzhen SiBiono GeneTech Recent Development

Table 72. SynerGene Therapeutics Company Detail

Table 73. SynerGene Therapeutics Business Overview

Table 74. SynerGene Therapeutics Cancer Gene Therapy Product

Table 75. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 76. SynerGene Therapeutics Recent Development

Table 77. Altor BioScience Company Detail

Table 78. Altor BioScience Business Overview

Table 79. Altor BioScience Cancer Gene Therapy Product

Table 80. Altor BioScience Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 81. Altor BioScience Recent Development

Table 82. Amgen Company Detail

Table 83. Amgen Business Overview

Table 84. Amgen Cancer Gene Therapy Product

Table 85. Amgen Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 86. Amgen Recent Development

Table 87. Argenx Company Detail

Table 88. Argenx Business Overview

Table 89. Argenx Cancer Gene Therapy Product

Table 90. Argenx Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 91. Argenx Recent Development

Table 92. BioCancell Company Detail

Table 93. BioCancell Business Overview

Table 94. BioCancell Cancer Gene Therapy Product

Table 95. BioCancell Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 96. BioCancell Recent Development

Table 97. GlaxoSmithKline Company Detail

Table 98. GlaxoSmithKline Business Overview

Table 99. GlaxoSmithKline Cancer Gene Therapy Product

Table 100. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 101. GlaxoSmithKline Recent Development

Table 102. Merck Company Detail

Table 103. Merck Business Overview

Table 104. Merck Cancer Gene Therapy Product

Table 105. Merck Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 106. Merck Recent Development

Table 107. OncoGenex Pharmaceuticals Company Detail

Table 108. OncoGenex Pharmaceuticals Business Overview

Table 109. OncoGenex Pharmaceuticals Cancer Gene Therapy Product

Table 110. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 111. OncoGenex Pharmaceuticals Recent Development

Table 112. Transgene Company Detail

Table 113. Transgene Business Overview

Table 114. Transgene Cancer Gene Therapy Product

Table 115. Transgene Revenue in Cancer Gene Therapy Business (2019-2024) & (US$ Million)

Table 116. Transgene Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Gene Therapy Market Share by Type: 2023 VS 2030

Figure 3. Oncolytic Virotherapy Features

Figure 4. Gene Transfer Features

Figure 5. Gene-Induced Immunotherapy Features

Figure 6. Global Cancer Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cancer Gene Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Diagnostics Centers Case Studies

Figure 10. Research Institutes Case Studies

Figure 11. Cancer Gene Therapy Report Years Considered

Figure 12. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cancer Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cancer Gene Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Cancer Gene Therapy Market Share by Players in 2023

Figure 16. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2023

Figure 18. North America Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cancer Gene Therapy Market Share by Country (2019-2030)

Figure 20. United States Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cancer Gene Therapy Market Share by Country (2019-2030)

Figure 24. Germany Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cancer Gene Therapy Market Share by Region (2019-2030)

Figure 32. China Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cancer Gene Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cancer Gene Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 47. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 48. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 49. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 50. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 51. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 52. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 53. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 54. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 55. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 56. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 57. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 58. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 59. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions